Evidence map›Paper›PMID 30539269›Full record

ArticlePsychopharmacology2019

Activation of somatodendritic 5-HT

Yulong Zhao, Elisabeth Y Bijlsma, Freija Ter Heegde, Monika P Verdouw, J Garssen, Adrian Newman-Tancredi, Lucianne Groenink

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yulong ZhaoDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Elisabeth Y BijlsmaDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Freija Ter HeegdeDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Monika P VerdouwDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
J GarssenDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Adrian Newman-TancrediNeurolixis Inc., Dana Point, CA, USA.
Lucianne GroeninkDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands. l.groenink@uu.nl.ORCID http://orcid.org/0000-0002-4971-7796
Utrecht University · NLNeurolixis (United States) · US

Funding

China Scholarship Council 201306300062
6 · The paper itself

Abstract

rationaleFear conditioning is an important factor in the etiology of anxiety disorders. Previous studies have demonstrated a role for serotonin (5-HT)

objectiveTo determine the role of pre- and post-synaptic 5-HT

methodsWe studied the acute effects of four 5-HT

resultsF13714 (0.16 mg/kg) and R(+)-8-OH-DPAT (0.03 mg/kg) injected before training reduced cued fear acquisition. Pre-treatment with F15599 or WAY100,635 had no effect on fear learning. In the fear-potentiated startle test, F13714 (0.04-0.16 mg/kg) and R(+)-8-OH-DPAT (0.1-0.3 mg/kg) reduced the expression of cued and contextual fear, whereas F15599 had no effect. WAY100,635 (0.03-1.0 mg/kg) reduced the overall startle response.

conclusionsThe current findings indicate that activation of somatodendritic 5-HT

Indexed as

Cues8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsAutoreceptorsDendritesFearLearningMaleRatsRats, WistarReceptor, Serotonin, 5-HT1AReflex, StartleSerotoninSerotonin 5-HT1 Receptor AgonistsSerotonin Antagonists8-Hydroxy-2-(di-n-propylamino)tetralinAutoreceptorsReceptor, Serotonin, 5-HT1ASerotoninSerotonin 5-HT1 Receptor AgonistsSerotonin AntagonistsAnxietyBiased agonistContextual anxietyCued fearFear conditioningFear learningFear-potentiated startleRatsserotonin1A receptor

Identifiers

PMID30539269
PMCPMC6591185
OpenAlexW2904135934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.